Biophytis S.A.
Biophytis S.A. (BPTS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BPTS · as of Jun 9, 2026
Key Statistics
Explore Biophytis S.A. Data
bpts stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
The BPTS analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $15.00, representing +82.48% upside from the current price of $8.22.
Competitors & Peers
bpts competitorsBPTS
AFMD
ARAV
EIGRQ
FRES
IDRAStock Performance
Full HistoryAbout Biophytis S.A.
Biophytis S.A. operates as a clinical-stage biotechnology firm dedicated to advancing therapeutic solutions aimed at decelerating degenerative processes and enhancing functional outcomes for individua…
what is biophytis s.a. · bpts stock overview · biophytis s.a. company profile · who is biophytis s.a. ceo · bpts NASDAQ · biophytis s.a. headquarters · biophytis s.a. business segments
About Stock Overview & Key Data
Biophytis S.A. (BPTS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 10, 2021. As of the latest trading session, BPTS stock price is $8.22, with a market capitalization of $2.6M. The stock has returned -91.81% over the past 12 months and -69.28% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Biophytis S.A. stock is Buy, with an average 12-month price target of $15.00. In fiscal year 2023, Biophytis S.A. reported revenue of — and net income of -$17.0M. For detailed data — including Biophytis S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biophytis S.A. (BPTS) stock price is $8.22. The stock is traded on NASDAQ under the ticker symbol BPTS. The 52-week range is $8.05 – $168.80.